EN PL
ORIGINAL PAPER
Analysis of selected factors, including vitamin D3 deficiency, affecting the quality of life of patients with rheumatoid arthritis
 
More details
Hide details
 
Submission date: 2013-08-02
 
 
Final revision date: 2013-11-01
 
 
Acceptance date: 2013-11-21
 
 
Online publication date: 2013-12-24
 
 
Publication date: 2013-12-20
 
 
Reumatologia 2013;51(6):415-421
 
KEYWORDS
TOPICS
ABSTRACT
Aim of the study: To evaluate quality of life of patients with rheumatoid arthritis (RA) and to determine the relationship between the quality of life (QoL) and age, disease duration and activity, joint damage and serum vitamin D3 concentration.
Material and methods: 119 consecutive RA patients (107 women and 12 men, aged 59.7 ±11.7 years) treated in the Department of Internal Diseases and Rheumatology WIM CSK MON, in whom serum vitamin D3 concentration was measured, were included in the study. The patients completed SF-36, the Beck Depression Inventory, the Health Assessment Questionnaire, and the severity of pain and general fatigue was determined on a visual-analog scale. Laboratory tests included: blood count, erythrocyte sedimentation rate (ESR), serum concentration of creatinine, calcium, phosphates and 25-hydroxycholecalciferol. Disease activity score (DAS28) was used to assess disease activity. In the statistical analysis the program Statistica version 10 was used.
Results: DAS28 was negatively correlated with the SF-36 and Beck depression scales. The patients with recent RA diagnosis had worse results than the other RA subjects in the depression scale and SF-36 domains associated with the impact of emotions and pain. The patients’ age, disease duration, degree of joint damage and 25(OH)D3 serum concentration did not correlate significantly with QoL indices.
Conclusions: Rheumatoid arthritis has an important impact on quality of life because of pain and physical impairment. The patients with recent RA diagnosis are more susceptible to suffer from increased pain and depressed mood than the patients with established disease. Disease activity has a weak negative influence on quality of life of RA patients. The role of vitamin D deficiency in deterioration of quality of life in RA needs further studies.
 
REFERENCES (28)
1.
Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2007; 66: 34-45.
 
2.
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-2581.
 
3.
Koligat D, Leszczyński P, Pawlak-Buś K i wsp. Ocena jakości życia pacjentów z reumatoidalnym zapaleniem stawów leczonych leflunomidem – przegląd literatury. Reumatologia 2012; 50: 227-232.
 
4.
Ware JE Jr, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA project. J Clin Epidemiol 1998; 51: 1159-1165.
 
5.
Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 11: 903-912.
 
6.
Costenbader KH, Feskanich D, Holmes M, et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67: 530-535.
 
7.
Cutolo M, Otsa K. Review: vitamin D, immunity and lupus. Lupus 2008; 17: 6-10.
 
8.
Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 2004; 50: 72-77.
 
9.
Anand S, Kaysen GA, Chertow GM, et al. Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. Nephrol Dial Transplant 2011; 26: 3683-3688.
 
10.
Huang W, Shah S, Long Q, et al. Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation. Clin J Pain 2013; 29: 341-347.
 
11.
Motsinger S, Lazovich D, MacLehose RF, et al. Vitamin D intake and mental health-related quality of life in older women: the Iowa Women’s Health Study. Maturitas 2012; 71: 267-273.
 
12.
Ecemis GC, Atmaca A. Quality of life is impaired not only in vitamin D deficient but also in vitamin D insufficient premenopausal women. J Endocrinol Invest 2013; PMD 23511484.
 
13.
Milaneschi Y, Shardell M, Corsi AM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 2010; 95: 3225-3233.
 
14.
Hoang MT, Defina LF, Willis BL, et al. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center Longitudinal study. Mayo Clin Proc 2011; 86: 1050-1055.
 
15.
Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580-1588.
 
16.
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 3: 315-324.
 
17.
Tylka J, Piotrowicz R. Kwestionariusz oceny jakości życia SF-36 – wersja polska. Kardiol Pol 2009; 67: 1166-1169.
 
18.
Picchianti-Diamanti A, Germano V, Ferlito C, et al. Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept. Qual Life Res 2010; 19: 821-826.
 
19.
Żołnierczyk-Zreda D, Wrześniewski K, Bugajska J i wsp. Polska wersja kwestionariusza SF-36v2 do badania jakości życia. CIOPPIB, Warszawa 2009; 71.
 
20.
Wysocka-Skurska I, Sierakowska M, Sierakowski S. Ocena pacjentów z reumatoidalnym zapaleniem stawów w zależności od stosowanej terapii farmakologicznej. Reumatologia 2012; 50: 16-23.
 
21.
Sierakowska M, Matys A, Kosior A i wsp. Ocena jakości życia pacjentów z reumatoidalnym zapaleniem stawów. Reumatologia 2006; 44: 298-303.
 
22.
Meenan R, Mason J, Anderson J, et al. AIMS-2: The content and properties of a revised and expanded arthritis impact measurement scales health status questionnaire. Arthritis Rheum 1992; 31: 714-720.
 
23.
Sherrer YS, Bloch DA, Mitchell DM, et al. Disability in rheumatoid arthritis: comparison of prognostic factors across three populations. J Rheumatol 1987; 14: 705-709.
 
24.
West E, Jonsson SW. Health-related quality of life in rheumatoid arthritis in Northern Sweden: a comparison between patients with early RA, patients with medium-term disease and controls, using SF-36. Clin Rheumatol 2005; 24: 117-122.
 
25.
Russell AS. Quality of life assessment in rheumatoid arthritis. Pharmacoeconomics 2008; 26: 831-846.
 
26.
Haroon N, Aggarwal A, Lawrence A, et al. Impact of rheumatoid arthritis on quality of life. Mod Rheumatol 2007; 17: 290-295.
 
27.
Standfield L, Norris S, Harvey C, et al. Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in Australian patients: a cross-sectional, multicenter study. Clin Ther 2010; 32: 1329-1342.
 
28.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top